Department of Epidemiology, GROW - School for Oncology and Reproduction, Maastricht University, P. Debyeplein 1, 6200 MD Maastricht, The Netherlands.
Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, Maastricht 6202 AZ, The Netherlands.
J Clin Epidemiol. 2022 Dec;152:127-139. doi: 10.1016/j.jclinepi.2022.09.019. Epub 2022 Oct 8.
Timely identification of colorectal cancer (CRC) survivors at risk of experiencing low health-related quality of life (HRQoL) in the near future is important for enabling appropriately tailored preventive actions. We previously developed and internally validated risk prediction models to estimate the 1-year risk of low HRQoL in long-term CRC survivors. In this article, we aim to externally validate and update these models in a population of short-term CRC survivors.
In a pooled cohort of 1,596 CRC survivors, seven HRQoL domains (global QoL, cognitive/emotional/physical/role/social functioning, and fatigue) were measured prospectively at approximately 5 months postdiagnosis (baseline for prediction) and approximately 1 year later by a validated patient-reported outcome measure (European Organization for Research and Treatment of Cancer Quality of life Questionnaire-Core 30). For each HRQoL domain, 1-year scores were dichotomized into low vs. normal/high HRQoL. Performance of the previously developed multivariable logistic prediction models was evaluated (calibration and discrimination). Models were updated to create a more parsimonious predictor set for all HRQoL domains.
Updated models showed good calibration and discrimination (AUC ≥0.75), containing a single set of 15 predictors, including nonmodifiable (age, sex, education, time since diagnosis, chemotherapy, radiotherapy, stoma, and comorbidities) and modifiable predictors (body mass index, physical activity, smoking, anxiety/depression, and baseline fatigue and HRQoL domain scores).
Externally validated and updated prediction models performed well for estimating the 1-year risk of low HRQoL in CRC survivors within 6 months postdiagnosis. The impact of implementing the models in oncology practice to improve HRQoL outcomes in CRC survivors needs to be evaluated.
及时识别出近期内有低健康相关生活质量(HRQoL)风险的结直肠癌(CRC)幸存者,对于采取适当的预防措施至关重要。我们之前开发并内部验证了风险预测模型,以估计长期 CRC 幸存者在一年内发生低 HRQoL 的风险。在本文中,我们旨在对短期 CRC 幸存者的队列进行外部验证和更新这些模型。
在一个包含 1596 名 CRC 幸存者的合并队列中,使用一种经过验证的患者报告结局测量工具(欧洲癌症研究与治疗组织生活质量问卷核心 30 版),在诊断后约 5 个月(预测的基线)和大约 1 年后,前瞻性地测量了七个 HRQoL 领域(总体 QoL、认知/情感/身体/角色/社会功能以及疲劳)。对于每个 HRQoL 领域,将 1 年的得分分为低与正常/高 HRQoL。评估了之前开发的多变量逻辑预测模型的性能(校准和区分)。更新了模型,为所有 HRQoL 领域创建了一个更简洁的预测因子集。
更新后的模型显示出良好的校准和区分能力(AUC≥0.75),包含一组 15 个预测因子,包括不可改变的因素(年龄、性别、教育程度、诊断后时间、化疗、放疗、造口术和合并症)和可改变的预测因子(体重指数、身体活动、吸烟、焦虑/抑郁以及基线疲劳和 HRQoL 领域得分)。
在诊断后 6 个月内,对结直肠癌幸存者进行外部验证和更新的预测模型可以很好地估计 1 年内低 HRQoL 的风险。需要评估在肿瘤学实践中实施这些模型以改善结直肠癌幸存者的 HRQoL 结局的效果。